Local injection with botulinum toxin A (BTX-A) safely and effectively reduces Raynaud’s phenomenon (RP) and nailfold small blood vessel, or capillary, abnormalities in women with scleroderma, according to data from a small study in China. Treatment also led to significant improvements in upper limb function in women with limited scleroderma, but not in those with diffuse disease... Comments are closed.
|
AuthorScleroderma Queensland Support Group Archives
December 2024
Categories
All
|